Related Experiment Video

Updated: May 30, 2026

Chemical-Induced Skin Carcinogenesis Model Using Dimethylbenz[a]Anthracene and 12-O-Tetradecanoyl Phorbol-13-Acetate (DMBA-TPA)
04:12

Chemical-Induced Skin Carcinogenesis Model Using Dimethylbenz[a]Anthracene and 12-O-Tetradecanoyl Phorbol-13-Acetate (DMBA-TPA)

Published on: December 19, 2019

Carcinogenesis in the Pituitary Dwarf Mouse. The Response to Dimethylbenzanthracene Applied to the Skin

F Bielschowsky, M Bielschowsky

    British Journal of Cancer
    |July 21, 2011
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells
    06:09

    Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells

    Published on: June 7, 2019

    Cell Population Analyses During Skin Carcinogenesis
    06:53

    Cell Population Analyses During Skin Carcinogenesis

    Published on: August 21, 2013

    Related Experiment Videos

    Last Updated: May 30, 2026

    Chemical-Induced Skin Carcinogenesis Model Using Dimethylbenz[a]Anthracene and 12-O-Tetradecanoyl Phorbol-13-Acetate (DMBA-TPA)
    04:12

    Chemical-Induced Skin Carcinogenesis Model Using Dimethylbenz[a]Anthracene and 12-O-Tetradecanoyl Phorbol-13-Acetate (DMBA-TPA)

    Published on: December 19, 2019

    Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells
    06:09

    Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells

    Published on: June 7, 2019

    Cell Population Analyses During Skin Carcinogenesis
    06:53

    Cell Population Analyses During Skin Carcinogenesis

    Published on: August 21, 2013

    Related Concept Videos

    Mutagenicity and Carcinogenicity01:25

    Mutagenicity and Carcinogenicity

    Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...

    Articles linked to this work by shared authors, journal, and citation graph.

    Osteosarcomas in NZBR/BI mice.

    Pathology·1979

    Menopausal hormone therapy and primary liver cancer: long-term follow-up of the women's health initiative randomized trials.

    British journal of cancer·2026

    Photodynamic immune stimulation eradicates primary pigmented melanoma and induces long-lasting anti-tumor immunity.

    British journal of cancer·2026

    Healthy lifestyle and cancer risk: a pan-cancer analysis in the UK Biobank prospective cohort.

    British journal of cancer·2026

    Unlocking the clock: a systematic review and meta-analysis on optimizing immune checkpoint inhibitor timing for advanced solid tumors.

    British journal of cancer·2026

    Preferences for the use of Artificial Intelligence (AI) technologies to help detect skin cancer in primary care settings: a UK-wide discrete choice experiment (DCE).

    British journal of cancer·2026

    Programmed death ligand 1 (PD-L1) PET/CT imaging to evaluate tumour saturation during atezolizumab treatment.

    British journal of cancer·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us